Search

Your search keyword '"Elia, Alessia"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Elia, Alessia" Remove constraint Author: "Elia, Alessia"
46 results on '"Elia, Alessia"'

Search Results

1. A multi-model analysis of the EU’s path to net zero

5. Where is the EU headed given its current climate policy? A stakeholder-driven model inter-comparison

6. Primary outcome reporting in clinical trials for older adults with depression

7. Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis

13. Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial

15. A Multi-Model Analysis of the EU's Path to Net Zero: Aligning Near-Term Action with Long-Term Visions

16. The interplay among COVID-19 economic recovery, behavioural changes, and the European Green Deal: An energy-economic modelling perspective

17. Global pathways & EU response: A 2nd European Regional, National and Sectoral assessment

18. USING MOTIVATION TO UNDERSTAND TREATMENT AND DECISION-MAKING IN PSYCHIATRIC ILLNESS

21. Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis

25. Additional file 1 of Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review

26. Additional file 2 of Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review

27. The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials

30. Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis

32. The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study

34. Quantifying the impact of energy technology innovation on cost reductions

35. The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment

36. Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial.

40. Additional file 1 of GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol

42. Additional file 1 of GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol

43. Additional file 1 of Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial

45. Additional file 1 of Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial

46. The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials.

Catalog

Books, media, physical & digital resources